Codes / ICD10CM / T38.995S

T38.995S Adverse effect of other hormone antagonists, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of other hormone antagonists, sequela

Summary

This condition represents the residual or chronic effects resulting from an adverse reaction to hormone antagonists not classified elsewhere, occurring as a sequela of the initial adverse event. It applies when the adverse effect has led to lasting physiological or functional changes, and the original cause is no longer active but the consequences persist.

Causes

The causes stem from prior exposure to hormone antagonists, which may have resulted from therapeutic use, incorrect dosing, or individual sensitivity. The sequela arises when the initial adverse effect causes irreversible or long-term damage to endocrine or related systems, even after the causative agent is no longer present.

Risk Factors

  • History of adverse reactions to hormone antagonists
  • Prolonged or high-dose exposure to these agents
  • Pre-existing endocrine or organ dysfunction
  • Individual sensitivity to hormonal substances
  • Delayed or inadequate management of the initial adverse event

Symptoms

Symptoms depend on the affected system and may include persistent metabolic disturbances, endocrine imbalances, or organ-specific dysfunction. Manifestations could range from chronic fatigue or hormonal dysregulation to organ damage, depending on the initial adverse effect and its sequelae.

Diagnosis

Diagnosis requires correlation of current symptoms with a documented history of prior adverse effects from hormone antagonists. Clinical assessment, including physical examination and relevant laboratory tests, helps identify residual damage or ongoing dysfunction linked to the original event.

Treatment Options

Treatment focuses on managing the sequelae and may include hormone replacement, symptom control, or rehabilitation. Interventions are tailored to the specific residual effects, such as addressing endocrine deficiencies or supporting organ function, while monitoring for further complications.

Prognosis and Follow-Up

Prognosis varies based on the severity and nature of the sequelae. Regular follow-up is essential to monitor for progression or improvement, with adjustments to treatment as needed. Long-term management may be required to address chronic symptoms or functional limitations.

Complications

Complications can include persistent endocrine disorders, organ damage, or reduced quality of life. In severe cases, sequelae may lead to disability or require ongoing medical intervention to maintain stability.

Lifestyle & Prevention

Lifestyle modifications may support management of sequelae, such as dietary adjustments or stress reduction. Prevention of future adverse effects involves careful medication review and adherence to prescribed regimens to avoid re-exposure to triggering agents.

When to Seek Professional Help

Seek medical attention if new or worsening symptoms occur, as these may indicate progression of sequelae or unrelated issues. Prompt evaluation is important for adjusting treatment or addressing emerging complications.

Tips for Medical Coders

Document the relationship between the sequela and the prior adverse effect of hormone antagonists clearly. Ensure the code is used only when the sequela is a direct result of the initial adverse event, and specify the affected body part or system if applicable.

Book a walkthrough

T38.995S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.